EU Call For Coronavirus Projects Sparks Big Pharma Interest
UK Participants Can Continue Beyond 2020
Executive Summary
Europe’s Innovative Medicines Initiative is calling for R&D projects aimed at tackling the spread of COVID-19, saying that collaborative ventures have the potential to accelerate the development of therapeutics and diagnostics to tackle this and future coronavirus outbreaks.
You may also be interested in...
Will The COVID-19 Pandemic Shake Up Access To Medicines?
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to be made available to those who need them. But industry says that relaxing IP protections is not the solution and that many companies have already invested significant amounts of money in potential new treatments and vaccines.
EU Funding For COVID-19 Drug & Diagnostic Research
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.
EU Firms Called In As Coronavirus Cases Soar
With cases of novel coronavirus infection rising at an alarming rate, the industry in Europe is being urged to contribute what it can by way of new products for detecting, diagnosing or treating the disease. Several research projects are also being run or started up with EU funding.